MDRSF 77.96 Stock Price Medartis Holding AG
Range: | 51.5-84.1 | Vol Avg: | 7 | Last Div: | 0 | Changes: | -26.46 |
Beta: | 0.96 | Cap: | 0.70B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Fri Jan 17 2020 | Empoloyees: | 860 |
CUSIP: | | CIK: | | ISIN: | CH0386200239 | Country: | CH |
CEO: | Dr. Christoph Bronnimann Ph.D. | Website: | https://www.medartis.com |
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.